STAT3 and cancer: Tang et al. showed that cancer cell-derived DAMP versican activated TLR2 in TME cells, and the induced IL-6 and IL-10 synergistically caused STAT3 activation in intratumoral DC, which resulted in their dysfunction in terms of directing Th1 and cytotoxic antitumor response [194].